CAS 5989-81-1|α-Lactose monohydrate
| Common Name | α-Lactose monohydrate | ||
|---|---|---|---|
| CAS Number | 5989-81-1 | Molecular Weight | 360.31 |
| Density | 1.53 g/cm3 | Boiling Point | 667.9ºC at 760 mmHg |
| Molecular Formula | C12H24O12 | Melting Point | 219ºC |
| MSDS | USA | Flash Point | 357.8ºC |
Names
| Name | α-Lactose monohydrate |
|---|---|
| Synonym | More Synonyms |
α-Lactose monohydrate BiologicalActivity
| Description | α-Lactose (hydrate) (α-D-Lactose (hydrate)) is the principal carbohydrate in the milk of most mammals. α-Lactose (hydrate) consists of glucose and galactose and exists in the form of two anomers, α and β. α-Lactose (hydrate) has many uses in the food and pharmaceutical industries, such as a free-flowing or agglomerating agent, a diluent for pigments, flavors, or enzymes[1][2][3]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Schuck, et al. Lactose crystallization: determination of α-lactose monohydrate in spray-dried dairy products. (2002). [2]. Johnson J M, et al. Lactose; Encyclopedia of Food Sciences and Nutrition[J]. 2003. |
Chemical & Physical Properties
| Density | 1.53 g/cm3 |
|---|---|
| Boiling Point | 667.9ºC at 760 mmHg |
| Melting Point | 219ºC |
| Molecular Formula | C12H24O12 |
| Molecular Weight | 360.31 |
| Flash Point | 357.8ºC |
| Exact Mass | 360.126770 |
| PSA | 198.76000 |
| Index of Refraction | 1.652 |
| InChIKey | WSVLPVUVIUVCRA-KPKNDVKVSA-N |
| SMILES | O.OCC1OC(OC2C(CO)OC(O)C(O)C2O)C(O)C(O)C1O |
| Storage condition | Store in air tight containers. |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| Risk Phrases | R40 |
| Safety Phrases | 24/25-36-26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
Articles3
More Articles| Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery. Eur. J. Pharm. Biopharm. 96 , 132-42, (2015) Co-administration of an inhaled corticosteroid and long acting beta agonist for chronic obstructive pulmonary disease has reduced mortality compared to either drug alone. This combination reduces exac... | |
| Continuous Processing of Active Pharmaceutical Ingredients Suspensions via Dynamic Cross-Flow Filtration. J. Pharm. Sci. 104 , 3481-9, (2015) Over the last years, continuous manufacturing has created significant interest in the pharmaceutical industry. Continuous filtration at low flow rates and high solid loadings poses, however, a signifi... | |
| Influence of the efavirenz micronization on tableting and dissolution. Pharmaceutics 4 , 430-41, (2013) The purpose of this study was to propose an analytical procedure that provides the effects of particle size and surface area on dissolution of efavirenz. Five different batches obtained by different m... |
Synonyms
| 4-O-β-D-Galactopyranosyl-α-D-glucopyranose hydrate (1:1) |
| α-D-Glucopyranose, 4-O-β-D-galactopyranosyl-, monohydrate |
| α-D-Glucopyranose, 4-O-β-D-galactopyranosyl-, hydrate (1:1) |
| MFCD00150747 |
| EINECS 200-559-2 |
| α-D(+)-Lactose monohydrate |
| α-Lactose monohydrate |
